GAO Shines Spotlight on Dearth of Antibacterial and Antifungal Treatments, Despite Special Pathway Available to Developers

There aren’t enough drugs under development to treat antibacterial and antifungal infections in patients with limited treatment options, even though the FDA offers a particular pathway to help expedite such candidates, the Government Accountability Office (GAO) has reported.
Source: Drug Industry Daily